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Abstract
Objective: The objective of this selective EBM review is to determine whether or not the use of
oral isotretinoin is more effective than oral antibiotics in the treatment of severe acne.
Study Design: Review of all English language primary studies published after year 2000.
Data Sources: Three randomized control trials all found using PubMed.
Outcomes Measured: Total number and percentage change in total acne lesions from baseline at
various intervals.
Results: A randomized control trial (RCT) by Gollnick et al. (2001) found that oral isotretinoin
was more effective than combination therapy involving minocycline in treating severe
inflammatory acne, but that isotretinoin caused more negative side effects. In a RCT by Oprica et
al. (2007), it was found that oral isotretinoin was more effective than tetracycline in treating acne
vulgaris with prolonged significant remission. A RCT by Tan et al. (2014) found that although
doxycycline induced earlier reduction in total acne lesions, isotretinoin was still superior in
reduction of acne lesions by week 20 of treatment.
Conclusions: All three RCT’s included in this study indicate that oral isotretinoin is more
effective than oral antibiotic therapies in the treatment of severe acne.
Keywords: isotretinoin, acne, antibiotics.
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Introduction
Acne vulgaris is a common dermatosis capable of producing significant psychological
and physical scarring. It is a disease of pilosebaceous follicles, involving follicular
hyperkeratinization, increased sebum production, bacterial growth within the follicle, and
inflammation.9 Therapy involving oral isotretinoin or oral antibiotics have long been mainstays
of treatment of severe acne vulgaris, and this paper evaluates three randomized controlled trials
comparing the overall effectiveness of each in acne treatment.
Research in treatments of acne is important to healthcare providers because acne can
cause significant psychological impairment to patients, affecting their work and social lives.
Acne is also the most common skin condition in the United States, affecting up to 50 million
Americans annually.2 The costs in the U.S. associated with the treatment of acne are greater than
$3 billion.1 There is not an exact estimate of healthcare visits due to acne, but according to a
2010 study, there were 39 million visits to dermatology offices alone, with acne being in the top
four reasons for visits.11
The sequence of events leading to acne lesions is not fully understood, but lesions are
brought on by plugging of the sebaceous follicle, increased sebum production, proliferation of
bacteria in the follicle, and then inflammation.4 An estimated 35-90% of adolescents experience
some form of acne, which tends to resolve by the third decade of life, but may still persist into
adulthood.9 Acne is a clinical diagnosis, and there is no universal classification system for the
severity of acne, but lesion counting and descriptions of the lesions, such as comedones, papules,
pustules and nodules usually help guide treatment.9
Treatment of mild acne usually begins with applying topical products containing benzoyl
peroxide.4 If that fails, second line treatment usually consists of prescription antibiotic cream,
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gel, or lotion.4 These treatments are followed by prescription topical retinoids or azelaic acid.4
Acne refractory to topical medications is then treated with oral antibiotics.4 Finally, if all
treatments fail, oral isotretinoin can be prescribed, which is usually held for last line treatment
due the potential for significant side effects associated with it.4
Oral Isotretinoin and oral antibiotics are accepted treatment options for severe acne
vulgaris, but isotretinoin is known to have more severe adverse effects than oral antibiotics,
including severe birth defects and excessively dry skin.6 Even though both medications treat
severe acne, it appears that effectiveness of isotretinoin is superior to antibiotics in reduction of
total acne lesions, and therefore may be worth the risk of adverse effects for some patients with
severe acne vulgaris refractory to prior treatments.
Objective
The objective of this systematic review is to determine whether or not the use of oral
isotretinoin is more effective than oral antibiotics in the treatment of severe acne.
Methods
Three randomized controlled trials were included in this systematic review. The studies
were selected based on populations studied, interventions used, comparisons made, and
outcomes measured. The populations studied in all three RCT’s consisted of patients greater than
12 years of age with moderate to severe facial acne. Gollnick et al.3 included males aged 15-31,
whereas Oprica et al.5 included male and female patients aged 15-35, and Tan et al.8 included
male and female patients aged 12-35.
For all studies included in this review, the intervention utilized was administration of oral
isotretinoin. For Gollnick et al.3, participants received oral isotretinoin at a cumulative dose of
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106-112 mg/kg for 6 months. Participants in the Oprica et al.5 study received oral isotretinoin at a
dose of 1 mg/kg/day in two divided doses for 6 months, and participants in the Tan et al.8 study
received oral isotretinoin at 1 mg/kg/day for 20 weeks.
Articles were researched via the PubMed database using key words such as isotretinoin,
antibiotics, and severe acne, and were selected based on relevance to the clinical question and
because outcomes included patient oriented evidence that matters (POEMs). All searches were
set for English language and all articles searched were published in peer reviewed journals.
Inclusion criteria for the purpose of this paper included randomized controlled studies that
included POEMs published after the year 2000. Exclusion criteria included previous Cochrane
reviews, previous student published systematic reviews, and individuals less than 12 years of
age. All studies used similar statistics to evaluate the outcomes where p-value is considered
statistically significant if it is less than or equal to 0.05. The demographics of the studies are
included and outlined below in Table 1.
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Table 1 – Demographics & Characteristics of included studies
Study
Type #Pts Age Inclusion
3
Gollnick RCT 85
15- Male patients
(2001)
31
with severe
inflammatory
acne.
Severity of acne
at > 4 on the
Leeds scale.
The face had to
display at least
2 deep
inflammatory
lesions.

Exclusion
W/D Interventions
Women and patients
8
Isotretinoin
with milder forms of
cumulative
acne.
dose of 106Patients with
112 mg/kg,
photosensitivity and/or
PO for 6
allergies to treatments.
months
Patients who have
VS.
received any systemic
Minocycline
treatment within 4
100 mg daily,
weeks of study or
PO for 6
topical treatment
months plus
within 2 weeks.
topical azelaic
acid cream
applied BID.

Oprica5
(2007)

RCT 52

1535

Male and
female patients,
ages 15-35,
with moderate
or severe
inflammatory
acne vulgaris

Tan8
(2014)

RCT 266

1235

Male and
female patients
of any race,
ages 12-35,
with severe
facial acne
vulgaris.
> 20
papules/pustules
and > 5 nodules

Patients with no
13
nodules, used
oral/topical acne
treatments within 8
weeks of study, used
systemic retinoids
within 12 months of
study, receiving drugs
that may interfere with
tetracycline, pregnant
or breastfeeding,
psychiatric or systemic
illness, other
dermatological issues,
participation in other
clinical trials.
Pregnancy
45

Isotretinoin 1
mg/kg/day in
two divided
doses, PO for
6 months
VS.
Tetracycline
hydrochloride
500 mg BID
plus topical
adapalene
once daily for
6 months

Isotretinoin 1
mg/kg-1 PO
QD for 20
weeks.
VS.
Doxycycline
200 mg PO
QD plus
topical agent
for 20 weeks
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Outcomes Measured
Each study measured the outcomes by counting the total number of acne lesions and the
percentage change in either total acne lesions or specific types of acne lesions, from baseline at
various intervals throughout the treatment period.
Results
In Gollnick et al.3, 85 male patients were used to compare use of oral isotretinoin and
minocycline combined with topical azelaic acid cream for six months. Patients were examined at
baseline and at one month intervals for the six month duration of the treatment. At each
examination, the examiner counted the patient’s total number of open and closed comedones,
inflammatory papules and pustules, nodes, nodules and cysts. Since total acne lesions were not
counted in this study, the papule and pustule counts are used for the comparison data. For the
isotretinoin group, the p-value was < 0.05, and thus proved to be statistically superior to the
combination minocycline treatment throughout the six month course of the study.
Table 2. Comparison of reduction of papules/pustules at end of month 6
Intervention

% Reduction in papules/pustules

P-value

Isotretinoin

97

< 0.05

Minocycline/AA cream

88

The Oprica et al.5 study employed 52 male and female patients to compare the use of oral
isotretinoin and tetracycline combined with topical adapalene cream. Clinical and
microbiological assessments were performed after 2, 4 and 6 months of treatment, and 2 months
after cessation of treatment. Patients treated with isotretinoin showed prolonged significant
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remission compared with the other group. Different types of lesions were counted at each
examination, but for the purpose of this study, comparison of total lesions at month six in the
male patients is utilized, although the p-value is < 0.05 in the female comparison as well. The
female comparison at six months showed a 91% decrease in total lesions with use of oral
isotretinoin, compared to a 63% decrease with use of the combination tetracycline therapy. The
male comparison of total lesions at six months showed an 87% decrease in lesions with use of
isotretinoin compared to a 43% decrease with the tetracycline, and thus demonstrated that oral
isotretinoin was statistically superior to the combination tetracycline treatment at the conclusion
of the six month study.
Table 3. Comparison of reduction of total acne lesions at end of month 6
Intervention

% Reduction of total lesions P-value

Isotretinoin

87%

Tetracycline/topical agent

43%

< 0.05

The Tan et al.8 study included 266 male and female patients to compare the use of oral
isotretinoin with doxycycline combined with a topical agent. The participants of this study were
examined for lesion counting at weeks: 2, 4, 8, 12, 16 and 20. For the purpose of this review,
results are shown for the examination at week 20 when treatment is complete, and females are
not excluded from this table, although they only comprise 39 of the 266 participants. By the end
of the treatment course, isotretinoin again demonstrated to be statistically superior to
doxycycline combined with a topical agent, with isotretinoin users showing a 93% reduction in
total acne lesions compared with a 78% reduction in doxycycline users. Isotretinoin was also
superior in reducing nodules (96% vs. 89%), and papules and pustules (95% vs. 80%).
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Table 4. Comparison of reduction of total acne lesions at week 20
Intervention

% Reduction of total lesions P-value

Isotretinoin

93%

Doxycycline/topical agent

78%

< 0.01

All three studies demonstrated that isotretinoin is superior to antibiotic therapy in the
reduction of acne lesions, with each study yielding a p-value less than 0.05. Using the control
event rate (CER) and experimental event rate (EER), the relative benefit increase (RBI) was
calculated followed by the absolute benefit increase (ABI). ABI shows an increase in treatment
effect with the isotretinoin group compared to the antibiotic group. The RBI represents the
effectiveness of isotretinoin and the relative probability of experiencing clinical improvement
with isotretinoin treatment compared to the antibiotic treatment studied in each article. The
number needed to treat (NNT) is calculated to determine the number of patients that need to
receive oral isotretinoin in order to benefit one patient with symptom improvement.
Table 5. Treatment Effects
Study

P-value

CER

EER

RBI

ABI

NNT

Gollnick

< 0.05

88%

97%

101%

9%

12

Oprica

< 0.05

43%

87%

100%

44%

3

Tan

< 0.01

78%

93%

19%

15%

7
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Discussion
Isotretinoin is widely known by the brand name Accutane, but this brand is no longer
available in the United States. It was taken off the market in the U.S. in 2009, but alternative
brands of Isotretinoin exist here in the U.S. Some of the brands available today include:
Absorica, Amnesteem, Claravis, Myorisan, and Zenatane.10
Isotretinoin is a teratogenic medication, and is not to be taken if you are pregnant or are
to become pregnant during the treatment course or within one month after its completion, as
severe birth defects and miscarriage can occur.10 To avoid these adverse effects, it is strongly
recommended for women of reproductive age to have two serum pregnancy tests obtained prior
to starting treatment, and each month thereafter while using isotretinoin.7 It is also recommended
that sexually active individuals use two forms of birth control during the duration of isotretinoin
use, and it is required for men and women to register with iPledge, which is a monitoring
program aimed at reducing exposure of the drug to pregnant individuals.7 In addition to the
teratogenic effects, isotretinoin has been linked to other serious side effects and can lead to
elevated liver enzymes and high triglyceride levels.7 For this reason, users are also required to
have blood drawn every four weeks to include: complete blood cell count (CBC), cholesterol,
triglyceride, and liver enzyme panel.7
In addition to use as a treatment for severe acne, isotretinoin has also been used to treat
other conditions. For individuals with discoid lupus erythematosus, isotretinoin is considered
effective at treating the hypertrophic lesions associated with the disease.7 Isotretinoin has also
shown to be effective in the treatment of the erythematous facial flares associated with rosacea.7
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The main limitation of this study was the small study size of two of the three articles.
Oprica et al.5 only included 52 participants, which may not be a sufficient size to make the
conclusion that isotretinoin is superior to minocycline in treatment of severe acne. Gollnick et
al.3 included 85 participants, which may also be considered small for this study. This article also
excluded women from the study, and did not provide statistics for reduction of the total number
of acne lesions, which led to the use of reduction of papules and pustules for the purposes of this
review. Tan et al.8 included 266 participants in the study, but despite the sufficient number of
participants, only 39 were females.
Conclusion
After reviewing these three studies, evidence strongly suggests that use of oral
isotretinoin is superior to oral antibiotic therapy in the treatment of severe acne in adults.
Although there were flaws in the studies, primarily the small sample size and the predominance
of males, the results were considered statistically significant in favor of oral isotretinoin in
reducing acne lesions. Of note, oral antibiotic therapy may still be a viable alternative to
isotretinoin in treatment of severe acne for some people, and these antibiotics will generally
cause fewer harmful side effects than isotretinoin. Future studies are warranted that include a
greater number of participants, specifically of the female gender.
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